AI-driven combination therapy

AI-powered discovery of synergistic drug combinations.

Combinate-Tx.ai uses artificial intelligence to identify drug combinations and targets, with the aim of developing more effective therapies with fewer side effects.

Conceptual protein surface with two complementary molecular interactions — Exploring combinations. Identifying targets.

Our approach

Inspired by biology. Guided by AI.

Biology relies on interacting signals. Our approach takes inspiration from nature's multi-hormonal signaling to explore combinations of drug targets.

We use AI to identify combinations with synergistic potential. Our aim is to improve treatment efficacy, reduce side effects, and accelerate discovery.

Explore the technology

Conceptual illustration of complementary molecules and multiple membrane receptors — Multiple targets. Combination possibilities.

Our research

Combination strategies for complex diseases.

Obesity

Harnessing GLP-1, GIP, and glucagon receptor pathways to enhance weight-loss treatments.

Discuss research

Inflammation & autoimmune disease

Identifying novel drug synergies to fine-tune immune responses.

Discuss research

Future research areas

Metabolic, cardiovascular, and neurological disorders are future areas of exploration.

Our technology

From biological data to combination insights.

01Analyze

02Predict

03Identify

Conceptual data layers, protein-interaction network, and complementary molecules

Analyze

Analyze genomic and biological data to explore relationships between targets.

Predict

Use AI to predict protein interactions and investigate combination potential.

Identify

Identify drug combinations and targets for further investigation.

What this research aims to enable

Improve therapeutic efficacy
Reduce side effects
Accelerate drug discovery
Explore repurposing existing drugs

Our team

Biological expertise. Shared mission.

Our team brings together pharmacology, bioinformatics, protein engineering, and AI to explore combination therapies.

Prof. Dmitry Veprintsev

Pharmacology & Drug Discovery Expert

Dr. Eline Koers

Bioinformatics & Protein Engineering Specialist

Bradley Morgan

AI & Machine Learning Innovator

Partner with us

Explore combination therapies together.

We collaborate with pharmaceutical companies, biotech innovators, and research institutions to accelerate drug development and bring transformative therapies to market.

Co-development

Work with us to design innovative treatments.

Target insights

Access proprietary AI-driven discovery data.

Research collaborations

Advance the science of combination therapy.

Investment & funding opportunities

We also welcome conversations about supporting AI-driven combination therapy research.